Physician profile
Sandeep Kodityal
NPI 1790820736
$221,768.75
in general payments reported to CMS, 2019-2025
82 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44K · 2020: $22K · 2021: $23K · 2022: $33K · 2023: $51K · 2024: $37K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $68K · Food and Beverage: $12K · Travel and Lodging: $9,986 · Consulting Fee: $7,618 · Education: $1,181 · Honoraria: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $68,159.00 |
| Food and Beverage | $11,793.62 |
| Travel and Lodging | $9,986.31 |
| Consulting Fee | $7,617.50 |
| Education | $1,181.23 |
| Honoraria | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $93,264.40 | 2019-2025 | Tagrisso, Calquence, Imfinzi |
| Lilly USA, LLC | $78,701.66 | 2019-2025 | Retevmo, Cyramza, Verzenio |
| Takeda Pharmaceuticals U.S.A., INC. | $17,021.28 | 2019-2025 | Ninlaro, Hyqvia |
| Mirati Therapeutics, INC. | $7,714.66 | 2023 | Krazati |
| Karyopharm Therapeutics INC. | $5,497.78 | 2021-2025 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $2,515.17 | 2019-2025 | Opdivo, Reblozyl, Augtyro |
| Pfizer INC. | $1,739.14 | 2019-2025 | |
| Amgen INC. | $1,317.06 | 2019-2023 | Kyprolis, Nplate, Xgeva |
| Janssen Biotech, INC. | $1,197.72 | 2019-2025 | Darzalex, Carvykti, Rybrevant |
| Astellas Pharma US INC | $1,116.12 | 2019-2025 | Padcev, Vyloy, Xtandi |
| Avyxa Pharma, LLC | $1,000.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $912.63 | 2019-2025 | |
| Celgene Corporation | $898.48 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $617.87 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Daiichi Sankyo INC. | $506.43 | 2021-2025 | Enhertu, Datroway, Injectafer |
Show all 82 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $433.23 | 2019-2025 | Ultomiris |
| Seagen INC. | $428.61 | 2019-2023 | Adcetris, Padcev |
| Bayer Healthcare Pharmaceuticals INC. | $375.86 | 2019-2025 | |
| Pharmaessentia USA Corporation | $370.13 | 2023-2025 | Besremi |
| Gilead Sciences, INC. | $368.38 | 2019-2025 | Trodelvy |
| Glaxosmithkline, LLC. | $355.86 | 2020-2025 | Ojjaara, Blenrep, Jemperli |
| Incyte Corporation | $322.61 | 2019-2025 | Monjuvi, Jakafi |
| Genzyme Corporation | $311.06 | 2019-2025 | |
| Adc Therapeutics America, INC. | $299.55 | 2023-2025 | |
| Eisai INC. | $267.33 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $221.93 | 2019-2025 | Libtayo, Lynozyfic |
| Beigene USA, INC. | $208.54 | 2020-2024 | Brukinsa |
| Tempus Ai, INC | $190.98 | 2025 | Xt Cdx |
| Genentech USA, INC. | $185.64 | 2019-2024 | Tecentriq, Alecensa, Rozlytrek |
| Abbvie INC. | $183.91 | 2023-2025 | |
| Adaptive Biotechnologies Corporation | $182.48 | 2022 | |
| Asd Specialty Healthcare, LLC | $182.46 | 2019 | |
| Rigel Pharmaceuticals, INC. | $175.80 | 2019-2025 | Rezlidhia, Tavalisse, Tavalisse |
| Beone Medicines USA, INC. | $174.57 | 2025 | Tevimbra, Brukinsa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.71 | 2019-2024 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $130.32 | 2019-2023 | Imbruvica, Epkinly |
| Puma Biotechnology, INC. | $122.22 | 2022-2025 | |
| Deciphera Pharmaceuticals INC. | $112.47 | 2022-2023 | Qinlock |
| Janssen Scientific Affairs, LLC | $107.68 | 2025 | Imbruvica, Talvey, Darzalex |
| Sobi, INC | $95.38 | 2022-2024 | |
| Verastem, INC. | $93.92 | 2019 | |
| Aveo Pharmaceuticals, INC. | $90.14 | 2023-2025 | Fotivda |
| Sanofi-Aventis U.S. LLC | $86.95 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $86.69 | 2019-2022 | |
| Taiho Oncology, INC. | $81.51 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $77.52 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $75.15 | 2020-2025 | Monoferric |
| Amneal Pharmaceuticals LLC | $74.97 | 2025 | Alymsys |
| Morphosys, US INC. | $68.47 | 2022-2023 | Monjuvi |
| Array Biopharma INC | $63.25 | 2021-2023 | Mektovi, Braftovi, Lorbrena |
| Cti Biopharma Corp. | $63.13 | 2022-2023 | Vonjo |
| Tersera Therapeutics LLC | $61.82 | 2021-2025 | Xermelo |
| Emd Serono, INC. | $61.44 | 2019-2024 | |
| Kite Pharma, INC. | $59.35 | 2020-2022 | |
| Stemline Therapeutics INC. | $48.78 | 2023-2025 | Orserdu |
| Dendreon Pharmaceuticals LLC | $45.50 | 2019 | |
| Springworks Therapeutics, INC. | $44.19 | 2024-2025 | Ogsiveo, Gomekli |
| Ipsen Biopharmaceuticals, INC | $42.32 | 2019-2022 | |
| Blueprint Medicines Corporation | $41.85 | 2023 | Ayvakit |
| Syndax Pharmaceuticals, INC. | $40.85 | 2025 | |
| Clovis Oncology, INC. | $33.44 | 2019 | |
| Dova Pharmaceuticals | $32.67 | 2021 | |
| Tesaro, INC. | $32.48 | 2019 | |
| Exelixis INC. | $28.55 | 2019 | |
| Shionogi INC | $27.42 | 2022 | |
| Tg Therapeutics, INC. | $26.23 | 2021 | |
| Myovant Sciences INC. | $25.65 | 2021 | |
| Boston Scientific Corporation | $25.40 | 2022 | |
| Immunocore Limited | $25.21 | 2024 | Kimmtrak |
| Acrotech Biopharma INC. | $23.27 | 2025 | Beleodaq |
| Alnylam Pharmaceuticals INC. | $23.03 | 2023 | Oxlumo |
| Teva Pharmaceuticals USA, INC. | $22.65 | 2019 | |
| Genmab U.S., INC. | $21.76 | 2025 | Epkinly |
| Kyowa Kirin, INC. | $19.88 | 2021 | |
| Myriad Genetic Laboratories, INC. | $19.40 | 2025 | Prolaris |
| Invivyd INC | $19.11 | 2025 | Pemgarda |
| Agios Pharmaceuticals, INC. | $18.47 | 2025 | Pyrukynd |
| Epizyme, INC. | $18.36 | 2020 | |
| Foundation Medicine, INC. | $16.70 | 2019 | |
| Mylan Institutional INC. | $15.08 | 2019 | |
| Heron Therapeutics, INC. | $14.42 | 2019 | |
| Sirtex Medical INC | $8.66 | 2023 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandeep Kodityal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.